Mylan’s Ogivri becomes first and only FDA-approved Herceptin biosimilar
December 4, 2017Sales and Marketing Biocon, Cancer, FDA, Herceptin, Mylan, Roche, biosimilar, pharma
The FDA has announced the approval of Mylan’s Ogivri (trastuzumab-dkst), the first biosimilar version of Roche’s Herceptin to be authorised …
J&J opts in on Idorsia’s candidate for $230m
December 4, 2017Sales and Marketing Idorsia, Johnson & Johnson, biotech, drugs, pharma, pharmaceutical
As part of Johnson & Johnson’s acquisition of Actelion, it was able to secure a number of ties with the …
Pharma carousel sees Bayer discovery chief head to Shire
December 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Shire, biotech, drugs, pharma, pharmaceutical
It’s no secret that when individuals leave companies within the pharma industry, they tend to pop up at a rival …
Top Ten most popular articles on Pharmafile.com this week
December 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
We’re officially into December and only one month away from the end of the year. Among our top news this …
Gottlieb looking to approve cancer treatments on earlier evidence
December 1, 2017Medical Communications FDA, Scott Gottlieb, biotech, drugs, pharma, pharmaceutical
Scott Gottlieb, FDA commissioner, was speaking in front of the House Committee on Energy and Commerce, regarding the 21st Century …
FDA approves first and only therapy of its kind for opioid addiction
December 1, 2017Medical Communications, Sales and Marketing FDA, Invidior, Sublocade, US, opioid crisis, opioids, pharma
Image Credit: Marco VerchAs the US languishes in the midst of an opioid crisis which President Trump declared national emergency …
Type 1 diabetes misunderstood as “disease of childhood”
December 1, 2017Medical Communications biotech, diabetes, drugs, pharma, pharmaceutical
New research published in The Lancet has revealed that type 1 diabetes cannot be understood as a “disease of the …
Novartis reveals strong long-term data Cosentyx in psoriasis of the hands and feet
December 1, 2017Medical Communications, Research and Development Cosentyx, Novartis, palmoplantar psoriasis, pharma, psoriasis
Novartis has released new data for Consentyx (secukinumab) which it claims make the IL-17A inhibitor “the first biologic to show …
Vir Biotech appoint “renowned scientist” to CSO position
November 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vir Biotechnology, biotech, drugs, pharma, pharmaceutical
Vir Biotechnology, a developer of treatments that induce protective and therapeutics immune responses, has hired a CSO with a strong …
What’s driving change in drug discovery and development?
November 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data, Lhasa limited, charity, drug discovery, pharma, pharmacovigilance
Dr Chris Barber, CEO of not-for-profit organisation and educational charity Lhasa Limited, discusses new innovations and ideas that are set …
ECG Kardia Band becomes first-ever FDA-approved medical device accessory for Apple Watch
November 30, 2017Sales and Marketing Electrocardiogram, FDA, Kardia Band, apple watch, pharma
The FDA has announced its approval of AliveCor’s Kardia Band, an electrocardiogram for use with the Apple Watch, marking the …
Sanofi admits to dangers of its dengue vaccine
November 30, 2017Sales and Marketing Sanofi, biotech, dengue, drugs, pharma, pharmaceutical
After analysing six years’ worth of data on its dengue vaccine, Dengvaxia, Sanofi contacted health authorities to tell them that …
Novartis’ Phase 3 migraine data could revolutionise treatment
November 30, 2017Research and Development CGRP, Novartis Amgen, biotech, drugs, migraine, pharma, pharmaceutical
Descriptions of treatments as ‘revolutionary’ or ‘ground-breaking’ are ten a penny in the pharmaceutical industry, very rarely do such treatments …
US federal government withdraws approval of major patient charity over donor misconduct
November 30, 2017Medical Communications, Sales and Marketing Caring Voice Coalition, US, US government, patient charity, pharma
The Department of Health and Human Services’ Office of Inspector General (OIG) has rescinded authorisation for one of the US’ …
European biotechs outperform US for investment return, report claims
November 29, 2017Medical Communications, Sales and Marketing EU, Europe, US, investment, pharma
A new report from RSA Group has revealed that European biotech companies are “significantly outperforming” their US counterparts in terms …
Human heart patch could repair dead tissue following heart attack
November 29, 2017Research and Development Duke University, heart, heart patch, human heart, pharma
A team of researchers and biomedical engineers at Duke University in North Carolina, US, have revealed that they have developed …
Pfizer’s Viagra Connect becomes first erectile dysfunction drug available over-the-counter in UK
November 29, 2017Research and Development, Sales and Marketing MHRA, Pfizer, Viagra Connect, erectile dysfunction, pharma, viagra
Pfizer has revealed that its erectile dysfunction treatment Viagra Connect (sildenafil) will now be available without a prescription through UK …
Gilead launches hep C drug Sovaldi in China at one-fifth of US price
November 29, 2017Research and Development, Sales and Marketing China, Gilead, hepatitis C, pharma, sovaldi
Gilead has officially launched its hepatitis C drug Sovaldi (sofosbuvir) in the Chinese market, but with one major caveat: it …
FDA unveils guidelines to help generic medical device versions reach the market
November 28, 2017Research and Development, Sales and Marketing FDA, Mylan, Scott Gottlieb, auto injector, auto-injector, epipen, pharma
The scandal surrounding Mylan’s price-hiking of its flagship EpiPen epinephrine auto-injector was the news of last summer, continuing to grab …
Merck KGaA and Pfizer’s Bavencio fails at Phase 3 in gastric cancer
November 28, 2017Research and Development Bavencio, Cancer, Merck, Pfizer, pharma
Merck KGaA and Pfizer have been rocked by the news that their jointly-developed anti-PD-L1 antibody failed to meet its primary …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
